Business
Viveve(R) Announces Election of Three New Independent Board Directors
Viveve(R) Announces Election of Three New Independent Board Directors.
About this update from Viveve Medical, Inc.
[{"type":"text","content":"\nViveve(R) Announces Election of Three New Independent Board Directors\n\nViveve(R) Announces Election of Three New Independent Board Directors\n\n\n SUNNYVALE, CA--(Marketwired - May 12, 2016) - Viveve Medical, Inc. (\"Viveve\") (OTCQB: VIVMD), a medical technology company focused on women's health, today announced the addition of three new members to the Viveve board of directors and the retirement of two current members. Lori Bush, Debora Jorn, and Arlene Morris joined the company's board of directors effective May 11, 2016. Mark Colella and Carl Simpson, long-time members of Viveve's board, retired. Lori Bush has over 30 years of experience in the consumer and healthcare products industries with a proven track record in building highly successful brands. Most recently, she served as president and chief executive officer of Rodan + Fields, a premium skincare company that grew from a start-up to over $600M in revenue during her 8 year tenure with the company. Ms. Bush's previous executive roles include president of Nu Skin and leadership positions in consumer products within Johnson & Johnson. Debora Jorn has extensive experience in building multi-billion dollar U.S. and global life science businesses. She has a proven record of designing and implementing innovative business and marketing strategies that have delivered double digit organic growth across numerous therapeutic areas. Most recently Ms. Jorn served as executive vice president and company group chair at Valeant, chief global marketing officer at Bausch & Lomb, and group vice president for women's health and fertility at Schering Plough. Arlene Morris joins the board with significant life science experience in the development of strategic partnerships and transactions, global marketing, product pipeline development and operations. She has served as president and chief executive officer of Syndax Pharmaceuticals and has held executive leadership positions at Johnson & Johnson's Ortho-McNeil Pharmaceutical, Scios, Coulter Pharmaceuticals, Clearview Projects, and Affymax. \"We are very pleased to enhance Viveve's board of directions with the high caliber of talent and experience brought to us by Ms. Bush, Ms. Jorn and Ms. Morris,\" said Patricia Scheller, Viveve's chief executive officer. \"We are confident that their individual and collective contributions...